Drug Pipeline

Dihydroartemisinin-piperaquine (DHA-PPQ) Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
0
Recruiting
1
Phase 3
4
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-09 NCT04978272
Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP)		 date change Primary completion pushed: 2026-08-31 -> 2027-05-05
2026-06-09 NCT04978272
Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP)		 date change Completion pushed: 2026-08-31 -> 2027-05-05
Active Studies by Phase
Phase 4
2
Phase 3
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07403643 Investigating the Pharmacology of Tafenoquine in Papua New Guinean Children With… Uncomplicated Malaria Not Yet Recruiting
NCT07246525 Intermittent Preventive Treatment of Malaria in School-age Children to Decrease Community… Malaria Not Yet Recruiting
Phase 3
NCT04978272 Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP) Malaria Active, Not Recruiting
Not specified
NCT07533136 Tafenoquine Combinations for Improved Radical Cure Efficacy of Plasmodium Vivax Uncomplicated P. Vivax Mono-infection Not Yet Recruiting
Sponsors Running Dihydroartemisinin-piperaquine (DHA-PPQ) Trials
Grant Dorsey, M.D, Ph.D. (1) University of California, San Francisco (1) Curtin University (1) Walter Reed Army Institute of Research (WRAIR) (1)
Get alerts when Dihydroartemisinin-piperaquine (DHA-PPQ) trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free